These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Optical coherence tomography for evaluation of neointimal proliferation after placement of a new drug eluting stent].
    Author: Liu CF, Chen YD, Chen L, Sun ZJ, Gai LY, Liu HB, Tian F, Bai QC, Guo K.
    Journal: Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1063-5. PubMed ID: 20501394.
    Abstract:
    OBJECTIVE: To evaluate neointimal proliferation following placement of a new drug-eluting stent (BUMA) by optical coherence tomography (OCT). METHODS: Twenty-two patients with coronary artery disease were randomized into BUMA group (n=15) and Endeavor group (n=7) and underwent OCT imaging after 9 months of stent implantation. RESULTS: The neointima hyperplasia (NIH) thickness in BUMA group were significantly smaller than that in endeavor group (0.220-/+0.140 mm vs 0.269-/+0.207 mm, P<0.001), and the uncovered Struts were significantly lower in BUMA group than in Endeavor group (5.65% vs 6.56%, P<0.0001). The luminal late loss in BUMA group was also significantly lower (34.87-/+11.50 vs 40.82-/+18.53, P=0.025). CONCLUSION: BUMA stent is safe and effective for treatment of coronary artery disease.
    [Abstract] [Full Text] [Related] [New Search]